Louis P. Garrison, Jr., PhD, is Professor Emeritus in The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute in the School of Pharmacy, and has been Adjunct Professor in the Departments of Global Health and Health Services at the University of Washington, where he joined the faculty in 2004. In October 2016, he became Senior Visiting Fellow at the Office of Health Economics, London, UK.
For the first 13 years of his career, Dr. Garrison worked in non-profit health policy research first at the Battelle Human Affairs Research Centers (Seattle), and then at the Project HOPE Center for Health Affairs (Virginia), where he was the Director from 1989-1992. Following this, he worked as an economist in the pharmaceutical industry for 12 years. From 2002-2004, he was Vice President and Head of Health Economics & Strategic Pricing in Roche Pharmaceuticals, based in Basel, Switzerland.
Dr. Garrison received a BA in Economics from Indiana University, and a PhD in Economics from Stanford University. He has more than 140 publications in peer-reviewed journals. His research interests include national and international health policy issues related to personalized medicine, benefit-risk analysis, insurance, pricing, reimbursement, and risk-sharing agreements, as well as the economic evaluation of pharmaceuticals, diagnostics, devices, surgical procedures, and vaccines, particularly as related to organ transplantation, influenza, measles, obesity, and cancer.
Dr. Garrison was elected as ISPOR President for July 2016-June 2017, and has just completed his final year on the Board Immediate Past President. From 2007-2009, he served on the ISPOR Board of Directors. He co-chaired two ISPOR Good Practice Task Forces—on Real-World Data and on Performance-Based Risk-Sharing Arrangements—and he chaired the ISPOR Health Science Policy Council from 2012 to 2015. He also recently co-chaired the ISPOR Special Task Force on U.S Value Frameworks, and is faculty advisor for the UW ISPOR Student Chapter. He is immediate past chair of the Past Presidents’ Council. He was selected in 2017 by PharmaVOICE as being among “100 of the Most Inspiring People” in the industry.